Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 4,004 | 3,326 | 2,210 | 2,226 | 2,248 |
| Operating Income | -4,004 | -3,326 | -2,210 | -2,226 | -2,248 |
| Interest Expense | 3 | 3 | 2 | 4 | 3 |
| Other Income | 312 | 3 | -334 | -148 | -122 |
| Pre-tax Income | -3,695 | -3,326 | -2,546 | -2,378 | -2,373 |
| Income Tax | -29 | 224 | -404 | -192 | -116 |
| Net Income Continuous | -3,666 | -3,550 | -2,142 | -2,186 | -2,257 |
| Net Income | $-3,666 | $-3,550 | $-2,142 | $-2,186 | $-2,257 |
| EPS Basic Total Ops | -6,552.55 | -6,150.15 | -3,843.84 | -5,285.29 | -5,525.53 |
| EPS Basic Continuous Ops | -6,552.98 | -6,214.64 | -3,873.50 | -5,203.26 | -5,483.64 |
| EPS Diluted Total Ops | -6,552.55 | -6,150.15 | -3,843.84 | -5,285.29 | -5,525.53 |
| EPS Diluted Continuous Ops | -6,552.98 | -6,214.64 | -3,873.50 | -5,203.26 | -5,483.64 |
| EBITDA(a) | $-4,004 | $-3,326 | $-2,210 | $-2,226 | $-2,248 |